The effects of clozapine on quinpirole-induced non-regulatory drinking and prepulse inhibition disruption in rats

Psychopharmacology

Volumn 212, Issue 1, 2010, Pages 105-115

  De Carolis, Lorenza ^a   Stasi, Maria Antonietta ^b   Serlupi Crescenzi, Ottaviano ^b   Borsini, Franco ^b   Nencini, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Sigma Tau SpA   (Italy)

Author keywords

Antipsychotic; BDNF; C Fos; Clozapine; Dopamine receptor; Drinking; Polydipsia; PPI; Quinpirole

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; PROTEIN C FOS; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRINKING BEHAVIOR; DRUG SENSITIVITY; FLUID INTAKE; GENE EXPRESSION; HIPPOCAMPUS; MALE; NONHUMAN; POLYDIPSIA; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CLOZAPINE; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; GENE EXPRESSION REGULATION; HALOPERIDOL; MALE; PROTO-ONCOGENE PROTEINS C-FOS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA;

EID: 77955775574     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1937-1     Document Type: Article

References (54)

1. D Amato MA Stasi F Borsini P Nencini 2008 Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia Psychopharmacology 200 157 165 10.1007/s00213-008- 1229-1 1:CAS:528:DC%2BD1cXhtFOjsLfK 18597076
2. A Badiani R Vaccaro R Burdino A Casini P Valeri TG Renda P Nencini 2002 Dissociation in the effects of the D2/D3 dopaminergic agonist quinpirole on drinking and on vasopressin levels in the rat Neurosci Lett 325 79 82 10.1016/S0304-3940(02)00261-6 1:CAS:528:DC%2BD38XktVarsLg%3D 12044626 (Pubitemid 34607199)
3. G Bersani L Pesaresi V Orlandi S Gherardelli P Pancheri 2007 Atypical antipsychotics and polydipsia: a cause or a treatment? Hum Psychopharmacol Mar 22 103 107 10.1002/hup.825 1:CAS:528:DC%2BD2sXltlSiu78%3D (Pubitemid 46505719)
4. Brookes G, Ahmed AG (2006) Pharmacological treatments for psychosis-related polydipsia Cochrane Database Syst Rev CD003544
5. CM Canuso MB Goldman 1999 Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome J Neuropsychiatry Clin Neurosci 11 86 90 1:CAS:528:DyaK1MXhtFyisrY%3D 9990561
6. DC Chen J Wang B Wang SC Yang CX Zhang YL Zheng, et al. 2009 Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes Psychopharmacology 207 375 380 10.1007/s00213-009-1665-6 1:CAS:528: DC%2BD1MXhtF2itrjN
7. J Chlan-Fourney P Ashe K Nylen AV Juorio XM Li 2002 Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration Brain Res 954 11 20 10.1016/S0006-8993(02)03215-8 1:CAS:528:DC%2BD38XotVektrg%3D 12393228 (Pubitemid 35223437)
8. P Chomczynski N Sacchi 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 156 159 10.1016/0003-2697(87)90021-2 1:CAS:528:DyaL2sXitFSns7Y%3D 2440339
9. I Cioli A Caricati P Nencini 2000 Quinpirole- and amphetamine-induced hyperdipsia: influence of fluid palatability and behavioral cost Behav Brain Res 109 9 18 10.1016/S0166-4328(99)00155-2 1:CAS:528:DC%2BD3cXhsVaisrg%3D 10699653 (Pubitemid 30107869)
10. KE Culm RP Hammer Jr 2004 Recovery of sensorimotor gating without G protein adaptation after repeated D2-like dopamine receptor agonist treatment in rats J Pharmacol Exp Ther 308 487 494 10.1124/jpet.103.057158 1:CAS:528:DC%2BD2cXhtlSqtLc%3D 14593083 (Pubitemid 38134209)
11. KE Culm AM Lim JA Onton RP Hammer Jr 2003 Reduced G(i) and G(o) protein function in the rat nucleus accumbens attenuates sensorimotor gating deficits Brain Res 982 12 18 10.1016/S0006-8993(03)02880-4 1:CAS:528:DC%2BD3sXmt1aiu70%3D 12915235 (Pubitemid 37288793)
12. KE Culm N Lugo-Escobar BT Hope RP Hammer Jr 2004 Repeated quinpirole treatment increases cAMP-dependent protein kinase activity and CREB phosphorylation in nucleus accumbens and reverses quinpirole-induced sensorimotor gating deficits in rats Neuropsychopharmacology 29 1823 1830 10.1038/sj.npp.1300483 1:CAS:528:DC%2BD2cXnslSmur4%3D 15138441 (Pubitemid 39336794)
13. SP Damask KA Bovenkerk G de la Pena KM Hoversten DB Peters AM Valentine JH Meador-Woodruff 1996 Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex Brain Res Mol Brain Res 41 241 249 10.1016/0169-328X(96)00101-5 1:CAS:528:DyaK28XkvFWrtbc%3D 8883957 (Pubitemid 26288166)
14. J De Leon C Verghese JI Tracy RC Josiassen GM Simpson 1994 Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature Biol Psychiatry 35 408 419 10.1016/0006-3223(94)90008-6 8018788 (Pubitemid 24118470)
15. AY Deutch RS Duman 1996 The effects of antipsychotic drugs on fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization Neuroscience 70 377 389 10.1016/0306-4522(95)00357-6 1:CAS:528:DyaK2MXhtVSmsL3E 8848147
16. N Durany J Thome 2004 Neurotrophic factors and the pathophysiology of schizophrenic psychoses Eur Psychiatry 19 326 337 10.1016/j.eurpsy.2004.06.020 15363470 (Pubitemid 39207958)
17. S Fraioli I Cioli P Nencini 1997 Amphetamine reinstates polydipsia induced by chronic exposure to quinpirole, a dopaminergic D2 agonist, in rats Behav Brain Res 89 199 215 10.1016/S0166-4328(97)00063-6 1:CAS:528: DyaK2sXnvFGqtrg%3D 9475627 (Pubitemid 28062711)
18. F Fumagalli R Santero M Gennarelli G Racagni MA Riva 2001 Decreased hippocampal BDNF expression after acute systemic injection of quinpirole Neuropharmacology 40 954 957 10.1016/S0028-3908(01)00017-X 1:CAS:528: DC%2BD3MXjvV2gurg%3D 11378166 (Pubitemid 32510809)
19. MA Geyer K Krebs-Thomson DL Braff NR Swerdlow 2001 Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology 156 117 154 10.1007/s002130100811 1:CAS:528:DC%2BD3MXmtlCqtLY%3D 11549216 (Pubitemid 32702206)
20. MB Goldman DJ Luchins GL Robertson 1988 Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia N Engl J Med 318 397 403 10.1056/NEJM198802183180702 1:STN:280:DyaL1c7it1aqtQ%3D%3D 3340117
21. MB Goldman G Wood MB Goldman M Gavin S Paul S Zaheer G Fayyaz, et al. 2007 Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients J Clin Endocrinol Metab 92 698 704 10.1210/jc.2006-1131 1:CAS:528:DC%2BD2sXitVakt7Y%3D 17118992
22. MB Goldman IJ Torres S Keedy M Marlow-O'Connor B Beenken R Pilla 2007 Reduced anterior hippocampal formation volume in hyponatremic schizophrenic patients Hippocampus 17 554 562 10.1002/hipo.20292 1:STN:280: DC%2BD2szntValtA%3D%3D 17427242 (Pubitemid 47068264)
23. A Hasbi T Fan M Alijaniaram T Nguyen ML Perreault BF O'Dowd SR George 2009 Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth Proc Natl Acad Sci U S A 106 21377 21382 10.1073/pnas.0903676106 1:CAS:528:DC%2BC3cXjvFGktrY%3D 19948956
24. ER Hawken JM Crookall D Reddick RC Millson R Milev N Delva 2009 Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: a retrospective study Schizophr Res 107 128 133 10.1016/j.schres.2008.09.029 18984069
25. RD Jindal AK Pillai SP Mahadik K Eklund DM Montrose MS Keshavan 2010 Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia Schizophr Res 119 47 51 10.1016/j.schres.2009.12.035 10.1016/j.schres.2009.12.035 20096541
26. A Liesbeth B Slot F Lestienne C Grevoz-Barret A Newman-Tancredi D Cussac 2009 F15063, a potential antipsychotic with dopamine D2/D3 receptor antagonist and 5-HT1A receptor agonist properties: Influence on immediate-early gene expression in rat prefrontal cortex and striatum Eur J Pharmacology 620 27 35 10.1016/j.ejphar.2009.08.019
27. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using realtime quantitative PCR and the 2-ΔΔcT method Methods 25 402 408 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D 11846609 (Pubitemid 34164012)
28. K Lombardo MA Stasi F Borsini 2009 Effects of ST2472, a novel antipsychotic, on prepulse inhibition Eur J Pharmacol 621 53 60 10.1016/j.ejphar.2009.08.035 1:CAS:528:DC%2BD1MXht1WrtrrM 19737551
29. A Malmberg DM Jackson A Eriksson N Mohell 1993 Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors Mol Pharmacol 43 749 754 1:CAS:528:DyaK3sXlsFWqtrY%3D 8099194
30. C Matsumoto T Shinkai V De Luca R Hwang H Hori M Lanktree, et al. 2005 Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia Int J Neuropsychopharmacol 8 245 253 10.1017/S1461145704004900 1:CAS:528:DC%2BD2MXjtlKru7Y%3D 15850500 (Pubitemid 40769265)
31. MJ McKinley MJ Cairns DA Denton G Egan ML Mathai A Uschakov, et al. 2004 Physiological and pathophysiological influences on thirst Physiol Behav 81 795 803 10.1016/j.physbeh.2004.04.055 1:CAS:528:DC%2BD2cXlsVWjt7c%3D 15234185 (Pubitemid 38845047)
32. J Meerabux Y Iwayama T Sakurai H Ohba T Toyota K Yamada, et al. 2005 Association of an orexin 1 receptor 408Val variant with polydipsia-hyponatremia in schizophrenic subjects Biol Psychiatry 58 401 407 10.1016/j.biopsych.2005.04. 015 1:CAS:528:DC%2BD2MXpslartLw%3D 15978554 (Pubitemid 41219708)
33. MJ Millan 2005 N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives Psychopharmacology 179 30 53 10.1007/s00213-005-2199-1 1:CAS:528: DC%2BD2MXjtV2iur0%3D 15761697 (Pubitemid 40576691)
34. S Miyamoto GE Duncan CE Marx JA Lieberman 2005 Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs Mol Psychiatry 10 79 104 10.1038/sj.mp.4001556 1:CAS:528:DC%2BD2cXhtFeisL3M 15289815 (Pubitemid 40139590)
35. P Nencini 1988 The role of opiate mechanisms in the development of tolerance to the anorectic effects of amphetamines Pharmacol Biochem Behav 30 755 764 10.1016/0091-3057(88)90095-0 1:CAS:528:DyaL1cXlt1antr4%3D 3211985 (Pubitemid 19271164)
36. P Nencini CE Johanson CR Schuster 1988 Sensitization to kappa opioid mechanisms associated with tolerance to the anorectic effects of cathinone J Pharmacol Exp Ther 245 147 154 1:CAS:528:DyaL1cXitFKhtr0%3D 2834534
37. MJ Robbins HM Critchlow A Lloyd J Cilia JD Clarke B Bond DN Jones PR Maycox 2008 Differential expression of IEG mRNA in rat brain following acute treatment with clozapine or haloperidol: a semi-quantitative RT-PCR study J Psychopharmacol 22 536 542 10.1177/0269881107081521 1:CAS:528:DC%2BD1cXhtFensLzE 18208916
38. N Rowland SM Antelman D Kocan 1981 Elevated water intake in rats treated chronically with amphetamine: drinking in excess of need? Appetite 2 51 66 1:STN:280:DyaL387lvV2ltQ%3D%3D 7337439
39. H Russig W Spooren S Durkin J Feldon BK Yee 2004 Apomorphine-induced disruption of prepulse inhibition that can be normalised by systemic haloperidol is insensitive to clozapine pretreatment Psychopharmacology 175 143 147 10.1007/s00213-004-1810-1 1:CAS:528:DC%2BD2cXnt1Grsbg%3D 14985922 (Pubitemid 39222343)
40. A Schotte PF Janssen AA Megens JE Leysen 1993 Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography Brain Res 631 191 202 10.1016/0006-8993(93)91535-Z 1:CAS:528:DyaK2cXpsFCqsA%3D%3D 7510574 (Pubitemid 24009988)
41. P Seeman D Weinshenker R Quirion LK Srivastava SK Bhardway DK Grandy, et al. 2005 Dopamine supersensitivity correlates with D2 high states, implying many paths to psychosis Proc Natl Acad Sci U S A 102 3513 3518 10.1073/pnas. 0409766102 1:CAS:528:DC%2BD2MXitl2ksrk%3D 15716360 (Pubitemid 40328076)
42. T Shinkai V De Luca K Utsunomiya S Sakata Y Inoue Y Fukunaka, et al. 2008 Functional polymorphism of the human multidrug resistance gene (MDR1) and polydipsia-hyponatremia in Schizophrenia Neuromol Med 10 362 367 10.1007/s12017-008-8041-2 1:CAS:528:DC%2BD1MXhtlKrsQ%3D%3D
43. NM Spears RA Leadbetter MS Shutty Jr 1996 Clozapine treatment in polydipsia and intermittent hyponatremia J Clin Psychiatry 57 123 128 1:CAS:528:DyaK28XmsFCjsrw%3D 8617697
44. AH Stonehouse FS Jones 2005 Bromocriptine and clozapine regulate dopamine 2 receptor gene expression in the mouse striatum J Mol Neurosci 25 29 36 10.1385/JMN:25:1:029 1:CAS:528:DC%2BD2MXktlahs7o%3D 15781964
45. NR Swerdlow GB Varty MA Geyer 1998 Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat? Neuropsychopharmacology 18 50 56 10.1016/S0893-133X(97)00110-3 1:CAS:528:DyaK2sXnvV2msbo%3D 9408918 (Pubitemid 28116373)
46. NR Swerdlow MA Geyer DL Braff 2001 Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges Psychopharmacology 156 194 215 10.1007/s002130100799 1:CAS:528: DC%2BD3MXmtlCqtbs%3D 11549223 (Pubitemid 32702213)
47. NR Swerdlow A Platten YK Kim I Gaudet J Shoemaker L Pitcher P Auerbach 2001 Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants Pharmacol Biochem Behav 70 219 226 10.1016/S0091-3057(01)00598-6 1:CAS:528:DC%2BD3MXotFWjtLo%3D 11701191 (Pubitemid 33049932)
48. NR Swerdlow JM Shoemaker HR Noh L Ma I Gaudet M Munson S Crain, et al. 2004 The ventral hippocampal regulation of prepulse inhibition and its disruption by apomorphine in rats are not mediated via the fornix Neuroscience 123 675 685 10.1016/j.neuroscience.2003.08.028 1:CAS:528:DC%2BD2cXosFSl 14706779 (Pubitemid 38045404)
49. NR Swerdlow SA Lelham AN Sutherland Owens WL Chang SD Sassen JA Talledo 2009 Pramipexole effects on startle gating in rats and normal men Psychopharmacology (Berl). 205 689 698 10.1007/s00213-009-1577-5 1:CAS:528:DC%2BD1MXmvFGnsbs%3D
50. C Verghese J De Leon GM Simpson 1993 Neuroendocrine factors influencing polydipsia in psychiatric patients: an hypothesis Neuropsychopharmacology 9 157 166 1:CAS:528:DyaK2cXhtVentLc%3D 8105791
51. C Verghese J de Leon RC Josiassen 1996 Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia Schizophr Bull 22 455 464 1:STN:280:DyaK2s%2FislWhug%3D%3D 8873296
52. FX Vollenweider MA Geyer 2001 A systems model of altered consciousness: integrating natural and drug-induced psychoses Brain Res Bull 56 495 507 10.1016/S0361-9230(01)00646-3 1:CAS:528:DC%2BD3MXptFylt7c%3D 11750795 (Pubitemid 34031785)
53. W Yamaguchi T Shinkai Y Inoue K Utsunomiya S Sakata Y Fukunaka, et al. 2009 Association analysis between the C-1291G polymorphism in the promoter region of the adrenergic alpha2A receptor gene and polydipsia in schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 33 499 502 10.1016/j.pnpbp.2009.01.012 1:CAS:528:DC%2BD1MXjslKksb8%3D 19439247
54. M Zink A Sartorius F Lederbogen 2004 Remission of polydipsia as antipsychotic effect of clozapine Eur Psychiatry 19 320 321 10.1016/j.eurpsy. 2004.04.005 1:STN:280:DC%2BD2czntlSjtA%3D%3D 15276669 (Pubitemid 38987848)